Integrate Advanced 3D Models with Scalability & Predictability to Supercharge Your Modeling Toolbox & Enhance Clinical Confidence
Following the FDA’s announcement of ‘Alternative Methods Working Group’ in the summer, 2021, Roche’s newly opened pRED innovation center in Basel, and exciting data from Recce Pharma’s anti-infective candidate using organoids, the 7th Annual 3D Tissue Models Summit will return to Boston in May 2022 to reunite the community of drug discovery and development experts. This is the definitive meeting for drug developers to explore and integrate complex 3D models featuring 30+ real-life case studies across 2 dedicated tracks and their lessons learned.
What’s Unique About the 7th 3D Tissue Models Summit?
- We are the only industry-focussed 3D tissue models summit delving into real-world applications for drug discovery and development with an industrial and regulatory environment in mind – not only for educational purpose but also form pre-competitive collaboration!
- We provide a unique platform for drug developers to exchange challenges, inspire solutions as well as assessing the latest technologies
This May you will learn from and meet trailblazers in 3D models to revolutionize your drug discovery and development protocols, giving you greater confidence in clinical relevancy and accelerating novel treatments to patients in a safe and affordable manner!
Previous Attendees Include:
